Page last updated: 2024-11-03

ono 1078 and Reperfusion Injury

ono 1078 has been researched along with Reperfusion Injury in 3 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamori, Y1
Komatsu, Y1
Kotani, T1
Kojima, S1
Takeuchi, K1
Zhang, WP2
Wei, EQ2
Mei, RH1
Zhu, CY1
Zhao, MH1
Fang, SH1
Zhou, Y1
Wang, ML1
Yu, GL1
Chu, LS1
Chen, Z1

Other Studies

3 other studies available for ono 1078 and Reperfusion Injury

ArticleYear
Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in mice.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Chromones; Gastric Ac

2010
Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.
    Acta pharmacologica Sinica, 2002, Volume: 23, Issue:10

    Topics: Animals; Blood-Brain Barrier; Brain Edema; Chromones; Infarction, Middle Cerebral Artery; Leukotrien

2002
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
    Neuroscience, 2006, Jul-07, Volume: 140, Issue:3

    Topics: Animals; Astrocytes; Brain Ischemia; Cerebral Infarction; Chromones; Disease Models, Animal; Encepha

2006